v3.3.1.900
CONDENSED CONSOLIDATING FINANCIAL INFORMATION - Statements of Cash Flows (Details) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:      
Net cash provided by operating activities $ 467,664,000 $ 297,302,000 $ 357,342,000
Cash flows from investing activities:      
Capital expenditures (333,423,000) (270,734,000) (260,823,000)
Proceeds from the disposition of long-term assets 604,000 238,000 3,880,000
Investments in non-consolidated entities (1,915,000) (1,522,000) (3,265,000)
Other, net (1,849,000) 327,000 (7,448,000)
Net cash used in investing activities (509,436,000) (271,691,000) (268,784,000)
Cash flows from financing activities:      
Capital contribution from Holdings     355,580,000
Proceeds from extension and modification of Term Loan due 2022 124,375,000    
Payment of initial public offering costs   (281,000)  
Borrowings under Revolver Credit Facility 75,000,000    
Principal payments under Term Loan (5,813,000) (7,750,000) (7,813,000)
Principal payments under capital and financing lease obligations (7,840,000) (6,941,000) (6,446,000)
Principal payments under promissory note (1,389,000) (1,389,000)  
Premium amount of coupon payment under Senior Subordinated Notes due 2020 (3,486,000)    
Increase in deferred financing costs (21,252,000) (7,952,000) (9,126,000)
Payment of construction payables     (19,404,000)
Cash used to pay dividends to Holdings (78,608,000) (58,504,000) (588,000)
Net cash provided by (used in) financing activities 35,286,000 (353,772,000) 324,928,000
Effect of exchange rate changes on cash and equivalents (363,000) 5,000 (103,000)
Net increase (decrease) in cash and cash equivalents (6,849,000) (328,156,000) 413,383,000
Cash and equivalents at beginning of period 216,155,000 544,311,000 130,928,000
Cash and equivalents at end of period 209,306,000 216,155,000 544,311,000
5.75 % Senior Subordinated Notes due 2025      
Cash flows from financing activities:      
Proceeds from issuance of Senior Subordinated Notes 600,000,000    
5.875% Senior Subordinated Notes due 2022      
Cash flows from financing activities:      
Proceeds from issuance of Senior Subordinated Notes   375,000,000  
9.75% Senior Subordinated Notes due 2020      
Cash flows from financing activities:      
Repurchase of Senior Subordinated Notes (645,701,000)    
Premium amount of coupon payment under Senior Subordinated Notes due 2020   (6,227,000)  
Senior Secured Credit Facility-Term Loan due 2020      
Cash flows from financing activities:      
Proceeds from issuance of Senior Subordinated Notes     773,063,000
8.75% Senior Notes due 2019      
Cash flows from financing activities:      
Repurchase of Senior Subordinated Notes   (639,728,000)  
Term loans due 2016      
Cash flows from financing activities:      
Principal payments under Term Loan     (464,088,000)
Term loans due 2018      
Cash flows from financing activities:      
Principal payments under Term Loan     (296,250,000)
AMCE      
Cash flows from operating activities:      
Net cash provided by operating activities 15,124,000 13,212,000 3,772,000
Cash flows from financing activities:      
Capital contribution from Holdings     355,580,000
Proceeds from extension and modification of Term Loan due 2022 124,375,000    
Borrowings under Revolver Credit Facility 75,000,000    
Principal payments under Term Loan (5,813,000) (7,750,000) (7,813,000)
Premium amount of coupon payment under Senior Subordinated Notes due 2020 (3,486,000)    
Increase in deferred financing costs (21,252,000) (7,952,000) (9,126,000)
Cash used to pay dividends to Holdings (78,608,000) (58,504,000) (588,000)
Change in intercompany advances (60,042,000) 331,867,000 (354,373,000)
Net cash provided by (used in) financing activities (15,527,000) (13,294,000) (3,595,000)
Net increase (decrease) in cash and cash equivalents (403,000) (82,000) 177,000
Cash and equivalents at beginning of period 403,000 485,000 308,000
Cash and equivalents at end of period   403,000 485,000
AMCE | 5.75 % Senior Subordinated Notes due 2025      
Cash flows from financing activities:      
Proceeds from issuance of Senior Subordinated Notes 600,000,000    
AMCE | 5.875% Senior Subordinated Notes due 2022      
Cash flows from financing activities:      
Proceeds from issuance of Senior Subordinated Notes   375,000,000  
AMCE | 9.75% Senior Subordinated Notes due 2020      
Cash flows from financing activities:      
Repurchase of Senior Subordinated Notes (645,701,000)    
Premium amount of coupon payment under Senior Subordinated Notes due 2020   (6,227,000)  
AMCE | Senior Secured Credit Facility-Term Loan due 2020      
Cash flows from financing activities:      
Proceeds from issuance of Senior Subordinated Notes     773,063,000
AMCE | 8.75% Senior Notes due 2019      
Cash flows from financing activities:      
Repurchase of Senior Subordinated Notes   (639,728,000)  
AMCE | Term loans due 2016      
Cash flows from financing activities:      
Principal payments under Term Loan     (464,088,000)
AMCE | Term loans due 2018      
Cash flows from financing activities:      
Principal payments under Term Loan     (296,250,000)
Subsidiary Guarantors      
Cash flows from operating activities:      
Net cash provided by operating activities 449,121,000 280,990,000 354,520,000
Cash flows from investing activities:      
Capital expenditures (333,395,000) (270,677,000) (260,633,000)
Proceeds from the disposition of long-term assets 604,000 238,000 3,880,000
Investments in non-consolidated entities (1,915,000) (1,522,000) (3,280,000)
Other, net (1,849,000) 327,000 (7,448,000)
Net cash used in investing activities (509,408,000) (271,634,000) (268,609,000)
Cash flows from financing activities:      
Payment of initial public offering costs   (281,000)  
Principal payments under capital and financing lease obligations (7,840,000) (6,941,000) (6,446,000)
Principal payments under promissory note (1,389,000) (1,389,000)  
Payment of construction payables     (19,404,000)
Change in intercompany advances 62,742,000 (328,651,000) 352,861,000
Net cash provided by (used in) financing activities 53,513,000 (337,262,000) 327,011,000
Effect of exchange rate changes on cash and equivalents (320,000) 34,000 (101,000)
Net increase (decrease) in cash and cash equivalents (7,094,000) (327,872,000) 412,821,000
Cash and equivalents at beginning of period 174,117,000 501,989,000 89,168,000
Cash and equivalents at end of period 167,023,000 174,117,000 501,989,000
Subsidiary Non-Guarantors      
Cash flows from operating activities:      
Net cash provided by operating activities 3,419,000 3,100,000 (950,000)
Cash flows from investing activities:      
Capital expenditures (28,000) (57,000) (190,000)
Investments in non-consolidated entities     15,000
Net cash used in investing activities (28,000) (57,000) (175,000)
Cash flows from financing activities:      
Change in intercompany advances (2,700,000) (3,216,000) 1,512,000
Net cash provided by (used in) financing activities (2,700,000) (3,216,000) 1,512,000
Effect of exchange rate changes on cash and equivalents (43,000) (29,000) (2,000)
Net increase (decrease) in cash and cash equivalents 648,000 (202,000) 385,000
Cash and equivalents at beginning of period 41,635,000 41,837,000 41,452,000
Cash and equivalents at end of period 42,283,000 $ 41,635,000 41,837,000
Rave      
Cash flows from investing activities:      
Acquisition     (1,128,000)
Rave | Subsidiary Guarantors      
Cash flows from investing activities:      
Acquisition     $ (1,128,000)
Starplex Cinemas      
Cash flows from investing activities:      
Acquisition (172,853,000)    
Starplex Cinemas | Subsidiary Guarantors      
Cash flows from investing activities:      
Acquisition $ (172,853,000)